Chronic Heart Failure Global Clinical Trials Review, H1, 2017
[Report Updated: 30-06-2017]

Introduction

Chronic Heart Failure Global Clinical Trials Review, H1, 2017

Summary

GlobalData's clinical trial report, “Chronic Heart Failure Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Heart Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Chronic Heart Failure Global Clinical Trials Review, H1, 2017 [Report Updated: 30-06-2017]

• Table of Contents

  Table of Contents 2

  List of Tables 4

  List of Figures 5

  Report Guidance 6

  GlobalData Clinical Trials Report Coverage 7

  Clinical Trials by Region 8

  Clinical Trials and Average Enrollment by Country 9

  Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

  Top Five Countries Contributing to Clinical Trials in Europe 13

  Top Countries Contributing to Clinical Trials in North America 14

  Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15

  Top Five Countries Contributing to Clinical Trials in Central and South America 16

  Clinical Trials by G7 Countries: Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials 17

  Clinical Trials by Phase in G7 Countries 19

  Clinical Trials in G7 Countries by Trial Status 20

  Clinical Trials by E7 Countries: Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials 21

  Clinical Trials by Phase in E7 Countries 23

  Clinical Trials in E7 Countries by Trial Status 24

  Clinical Trials by Phase 26

  In Progress Trials by Phase 27

  Clinical Trials by Trial Status 28

  Clinical Trials by End Point Status 30

  Subjects Recruited Over a Period of Time 31

  Clinical Trials by Sponsor Type 32

  Prominent Sponsors 33

  Top Companies Participating in Chronic Heart Failure Therapeutics Clinical Trials 35

  Prominent Drugs 37

  Latest Clinical Trials News on Chronic Heart Failure 38

  Apr 10, 2017: Successful Interim Analysis of Efficacy Endpoint In Mesoblasts Phase 3 Trial for Chronic Heart Failure 38

  Mar 31, 2017: Independent Data Monitoring Committee Initiates Process for Interim Analysis of Mesoblasts Phase 3 Chronic Heart Failure Trial 38

  Clinical Trial Profile Snapshots 40

  Appendix 271

  Abbreviations 271

  Definitions 271

  Research Methodology 272

  Secondary Research 272

  About GlobalData 273

  Contact Us 273

  Source 273

List Of Tables
in Chronic Heart Failure Global Clinical Trials Review, H1, 2017 [Report Updated: 30-06-2017]

List of Tables

Chronic Heart Failure Therapeutics, Global, Clinical Trials by Region, 2017* 8

Chronic Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 10

Chronic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11

Chronic Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 12

Chronic Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 13

Chronic Heart Failure Therapeutics Clinical Trials, North America, Top Countries, 2017* 14

Chronic Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 15

Chronic Heart Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 16

Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 18

Chronic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19

Chronic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20

Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 22

Chronic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23

Chronic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 25

Chronic Heart Failure Therapeutics, Global, Clinical Trials by Phase, 2017* 26

Chronic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 27

Chronic Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2017* 29

Chronic Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30

Chronic Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31

Chronic Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 32

Chronic Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 34

Chronic Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 36

Chronic Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37

List Of Figures, Charts and Diagrams
in Chronic Heart Failure Global Clinical Trials Review, H1, 2017 [Report Updated: 30-06-2017]

List of Figures

Chronic Heart Failure Therapeutics, Global, Clinical Trials by Region (%), 2017* 8

Chronic Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9

Chronic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11

Chronic Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 12

Chronic Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 13

Chronic Heart Failure Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 14

Chronic Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 15

Chronic Heart Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 16

Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 17

Chronic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19

Chronic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20

Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 21

Chronic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23

Chronic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 24

Chronic Heart Failure Therapeutics, Global, Clinical Trials by Phase (%), 2017* 26

Chronic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 27

Chronic Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2017* 28

Chronic Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30

Chronic Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31

Chronic Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 32

Chronic Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 33

Chronic Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 35

Chronic Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37

GlobalData Methodology 272

Additional Details

Publisher

Global Data

Publisher Information

Reference

111374 | GDHC4294CTIDB

Number of Pages

273

Report Format

PDF

Related Reports